Edition:
United States

Horizon Pharma PLC (HZNP.OQ)

HZNP.OQ on NASDAQ Stock Exchange Global Select Market

16.80USD
3:59pm EST
Change (% chg)

$-0.06 (-0.36%)
Prev Close
$16.86
Open
$16.95
Day's High
$17.11
Day's Low
$16.75
Volume
569,507
Avg. Vol
920,728
52-wk High
$23.43
52-wk Low
$13.06

HZNP.OQ

Chart for HZNP.OQ

About

Horizon Pharma plc, formerly Vidara Therapeutics International Public Limited Company, is a biopharmaceutical company. The Company is focused on identifying, developing, acquiring or in-licensing and commercializing differentiated products. It markets approximately nine medicines through its orphan, primary care and rheumatology... (more)

Overall

Beta: 1.76
Market Cap(Mil.): $2,718.80
Shares Outstanding(Mil.): 161.26
Dividend: --
Yield (%): --

Financials

  HZNP.OQ Industry Sector
P/E (TTM): -- 29.62 30.50
EPS (TTM): -0.08 -- --
ROI: -0.45 15.43 14.85
ROE: -0.94 16.61 16.27

BRIEF-Raptor Pharma says to pay Horizon Pharma termination fee of $30 mln if deal terminated

* In connection with termination of merger, Raptor will be required to pay to Horizon Pharma a termination fee of $30 million Source text for Eikon: [http://bit.ly/2celZU2] Further company coverage:

Sep 12 2016

BRIEF-Horizon pharma Q2 diluted earnings per share $0.09

* Horizon Pharma Plc announces second-quarter 2016 financial results

Aug 08 2016

Earnings vs. Estimates